ILANS

ILANS (Instituto Latinoamericano de Neurología y Sistema Nervioso) is a leading healthcare service provider network based in Bogotá, Colombia, specializing in neurology and the nervous system. Acquired by Khiron Life Sciences in 2018, the company operates a network of clinics that provide medical and surgical treatments for neurological, psychiatric, respiratory, and orthopedic conditions. ILANS is a central component of Khiron's "seed-to-patient" strategy, serving as a primary distribution channel for medical cannabis products in Latin America. The network treats over 100,000 patients annually and has expanded its services through the Zerenia brand to include integrated medical care and teleconsultation.